News

Nathealth, the apex body representing the Indian healthcare industry, has welcomed Honourable Prime Minister Narendra Modi’s recent announcement on forthcoming GST reforms, calling it a timely ...
Illumina Inc., a global leader in DNA sequencing and array-based technologies, announced today the appointment of Nilesh Shah as head of region, AMEA, effective immediately. Nilesh brings over 25 ...
Agilus Diagnostics, a subsidiary of Fortis Healthcare has opened its latest Diagnostic centre at Kuvempunagar, Mysuru. The new lab offers access to a suite of diagnostic and preventive healthcare ...
Genprex, Inc., a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced that the US Patent and Trademark Office has issued a ...
There is a need to prioritise pharma in all Foreign Trade Agreements (FTAs) and support for smaller exporters among other Government priority initiatives to boost pharma trade, according to Sanjaya ...
At its15th general body meeting recently, the Chennai-based Consortium of Indian Pharmaceutical Marketers and Manufacturers Associations (CIPMMA) passed a resolution urging the Union Health Ministry ...
Ascletis Pharma Inc., a fully integrated biotechnology company, announces encouraging preclinical efficacy results for ASC47, a first-in-class muscle-preserving weight loss drug candidate for the ...
Exports of drugs and pharmaceuticals from the country registered around 14 per cent growth in the month of July, while imports reported an increase of around 13.3 per cent compared to the same month ...
Livlong 365, one of India’s fastest-growing OPD and health-tech platforms, has announced plans to open 100 physical branches by 2027 as part of a major push to strengthen its nationwide presence. The ...
Galvanize Therapeutics, a biomedical platform company operating at the convergence of engineering, biology, and healthcare delivery, announced the enrollment of the first patient in the PROPEL ...
Indian pharma industry’s diversification into European markets is acting as a buffer against US trade shocks, says Parag Bhatia, director, Laborate Pharmaceuticals. Bhatia informs that Indian pharma ...
Pilatus Biosciences Inc, a biopharmaceutical company developing novel metabolic checkpoint immunotherapies for liver and gastrointestinal cancers, announced a clinical trial collaboration with Roche.